Company Analysis

Novavax, Inc. (NVAX)

Nasdaq: NVAX · Biological Products, (No Diagnostic Substances) · Gaithersburg, MD · filing with the SEC since 1996
Grade5.5
◀ Past 5.3● Present 5.7▶ Future 5.6
1 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 26, 2026Feb 27, 2025Feb 28, 2024Feb 28, 2023Mar 1, 2022Mar 1, 2021Mar 11, 2020Mar 18, 2019Mar 14, 2018Feb 27, 2017
Revenue1,123,479682,162983,7051,981,8721,146,290475,59818,66234,28831,17615,353
Cost of revenue73,040202,739343,768902,63900····
Research and development342,320391,169737,5021,235,2782,534,508747,027113,842173,797168,435237,939
Selling, general and administrative157,479337,185468,946488,691······
General and administrative··468,946488,691298,358145,29034,41734,40934,45146,527
Total costs and expenses670,684931,0931,550,2162,626,6082,832,866892,317139,243208,206202,886284,466
Operating income452,795-248,931-566,511-644,736-1,686,576-416,719-120,581-173,918-171,710-269,113
Interest expense11,52710,43011,46814,03913,61213,61213,61213,61213,61212,545
Interest and investment income29,50037,20020,100·1,3641,0141,5122,6741,9462,143
Other income (expense), net40,63340,44237,89610,969-6,833r13,605r-1310867-31
Income before income taxes442,167-176,615-543,031-653,647-1,714,536-418,259-132,694···
Income tax expense1,86510,8842,0314,29229,21500···
Net income440,302-187,499-545,062-657,939-1,743,751-418,259-132,694-184,748-183,769-279,966
Net income to common shareholders440,302-187,499-545,062·······
Earnings per share, basic2.72-1.23-5.41-8.42-23.44-7.27-5.51···
Earnings per share, diluted2.58-1.23-5.41-8.42-23.44-7.27-5.51···
Earnings per share, basic and diluted·····-7.27-5.51-9.99r-12.56r-1.03
Weighted average shares, basic161,991152,190100,76878,18374,40057,55424,100···
Weighted average shares, diluted173,103152,190100,76878,18374,40057,55424,100···
Weighted average shares, basic and diluted·····57,55424,10018,488r14,633r270,802r
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseDebt
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
us-gaap:InvestmentIncomeNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton NVAX · research, not advice